Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.45458203 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.45458203 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.27595688 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.27595688 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.95813079 |
6 | tryptophan catabolic process (GO:0006569) | 5.60009674 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.60009674 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.60009674 |
9 | kynurenine metabolic process (GO:0070189) | 5.54465140 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50039367 |
11 | mannose metabolic process (GO:0006013) | 5.49204332 |
12 | glyoxylate metabolic process (GO:0046487) | 5.44414023 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.40799202 |
14 | lysine catabolic process (GO:0006554) | 5.31014318 |
15 | lysine metabolic process (GO:0006553) | 5.31014318 |
16 | tryptophan metabolic process (GO:0006568) | 5.27761494 |
17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.26556080 |
18 | bile acid biosynthetic process (GO:0006699) | 5.06988461 |
19 | sulfur amino acid catabolic process (GO:0000098) | 4.79750620 |
20 | cysteine metabolic process (GO:0006534) | 4.69940715 |
21 | regulation of triglyceride catabolic process (GO:0010896) | 4.62582886 |
22 | amino-acid betaine metabolic process (GO:0006577) | 4.61446839 |
23 | urea cycle (GO:0000050) | 4.61093506 |
24 | urea metabolic process (GO:0019627) | 4.61093506 |
25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.59103868 |
26 | * 2-oxoglutarate metabolic process (GO:0006103) | 4.58213097 |
27 | ethanol oxidation (GO:0006069) | 4.57834958 |
28 | serine family amino acid catabolic process (GO:0009071) | 4.49309415 |
29 | valine metabolic process (GO:0006573) | 4.47379402 |
30 | homocysteine metabolic process (GO:0050667) | 4.45745983 |
31 | complement activation, alternative pathway (GO:0006957) | 4.41727164 |
32 | protein carboxylation (GO:0018214) | 4.35287381 |
33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.35287381 |
34 | fatty acid beta-oxidation (GO:0006635) | 4.34235206 |
35 | bile acid metabolic process (GO:0008206) | 4.30917614 |
36 | negative regulation of fibrinolysis (GO:0051918) | 4.30077657 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.29571644 |
38 | regulation of protein activation cascade (GO:2000257) | 4.29091354 |
39 | alpha-amino acid catabolic process (GO:1901606) | 4.26954321 |
40 | cellular ketone body metabolic process (GO:0046950) | 4.26829572 |
41 | nitrogen cycle metabolic process (GO:0071941) | 4.22823263 |
42 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.19686747 |
43 | fatty acid oxidation (GO:0019395) | 4.11629387 |
44 | acylglycerol homeostasis (GO:0055090) | 4.10848247 |
45 | triglyceride homeostasis (GO:0070328) | 4.10848247 |
46 | regulation of cholesterol esterification (GO:0010872) | 4.08420391 |
47 | regulation of fibrinolysis (GO:0051917) | 4.06483568 |
48 | negative regulation of cholesterol transport (GO:0032375) | 4.05316772 |
49 | negative regulation of sterol transport (GO:0032372) | 4.05316772 |
50 | short-chain fatty acid metabolic process (GO:0046459) | 4.05123749 |
51 | regulation of complement activation (GO:0030449) | 4.03074586 |
52 | lipid oxidation (GO:0034440) | 4.03024419 |
53 | reverse cholesterol transport (GO:0043691) | 4.02999375 |
54 | acetyl-CoA metabolic process (GO:0006084) | 4.01385675 |
55 | fatty acid catabolic process (GO:0009062) | 4.00786218 |
56 | plasma lipoprotein particle clearance (GO:0034381) | 4.00785970 |
57 | glycine metabolic process (GO:0006544) | 3.97727123 |
58 | coenzyme catabolic process (GO:0009109) | 3.96585496 |
59 | cellular amino acid catabolic process (GO:0009063) | 3.96100260 |
60 | tyrosine metabolic process (GO:0006570) | 3.94077368 |
61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.93608748 |
62 | protein-lipid complex remodeling (GO:0034368) | 3.93608748 |
63 | macromolecular complex remodeling (GO:0034367) | 3.93608748 |
64 | cellular biogenic amine catabolic process (GO:0042402) | 3.90855817 |
65 | amine catabolic process (GO:0009310) | 3.90855817 |
66 | aspartate family amino acid catabolic process (GO:0009068) | 3.89650787 |
67 | monocarboxylic acid catabolic process (GO:0072329) | 3.86911334 |
68 | phospholipid efflux (GO:0033700) | 3.85633260 |
69 | indolalkylamine metabolic process (GO:0006586) | 3.84542168 |
70 | carnitine metabolic process (GO:0009437) | 3.79745078 |
71 | organic acid catabolic process (GO:0016054) | 3.74469370 |
72 | carboxylic acid catabolic process (GO:0046395) | 3.74469370 |
73 | phospholipid homeostasis (GO:0055091) | 3.74465978 |
74 | benzene-containing compound metabolic process (GO:0042537) | 3.73902300 |
75 | cellular modified amino acid catabolic process (GO:0042219) | 3.73492135 |
76 | serine family amino acid metabolic process (GO:0009069) | 3.72768798 |
77 | branched-chain amino acid catabolic process (GO:0009083) | 3.70639740 |
78 | fatty acid transmembrane transport (GO:1902001) | 3.67556309 |
79 | ketone body metabolic process (GO:1902224) | 3.67356207 |
80 | tricarboxylic acid metabolic process (GO:0072350) | 3.63977196 |
81 | cellular glucuronidation (GO:0052695) | 3.61132682 |
82 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60700378 |
83 | branched-chain amino acid metabolic process (GO:0009081) | 3.60588770 |
84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.59534265 |
85 | bile acid and bile salt transport (GO:0015721) | 3.58072591 |
86 | positive regulation of histone deacetylation (GO:0031065) | 3.55978514 |
87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.54949932 |
88 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.54949932 |
89 | regulation of cholesterol metabolic process (GO:0090181) | 3.54154589 |
90 | serine family amino acid biosynthetic process (GO:0009070) | 3.53022647 |
91 | positive regulation of lipid catabolic process (GO:0050996) | 3.52258902 |
92 | imidazole-containing compound metabolic process (GO:0052803) | 3.50974401 |
93 | glutamate metabolic process (GO:0006536) | 3.44299736 |
94 | biotin metabolic process (GO:0006768) | 3.43061385 |
95 | carnitine shuttle (GO:0006853) | 3.41131895 |
96 | plasma lipoprotein particle assembly (GO:0034377) | 3.39886476 |
97 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.39858131 |
98 | regulation of ARF GTPase activity (GO:0032312) | 3.36092859 |
99 | cholesterol homeostasis (GO:0042632) | 3.35743313 |
100 | cholesterol efflux (GO:0033344) | 3.34104240 |
101 | thymic T cell selection (GO:0045061) | 3.33883110 |
102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.32665821 |
103 | drug transmembrane transport (GO:0006855) | 3.31788862 |
104 | regulation of cholesterol homeostasis (GO:2000188) | 3.30971135 |
105 | negative regulation of lipase activity (GO:0060192) | 3.29752509 |
106 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.28717514 |
107 | negative regulation of cell size (GO:0045792) | 3.25933118 |
108 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.11617448 |
109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11427805 |
110 | positive regulation of protein kinase C signaling (GO:0090037) | 3.06707150 |
111 | semaphorin-plexin signaling pathway (GO:0071526) | 3.05788090 |
112 | positive thymic T cell selection (GO:0045059) | 3.04200840 |
113 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01812509 |
114 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.92941910 |
115 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.92096790 |
116 | regulation of extracellular matrix disassembly (GO:0010715) | 2.91569879 |
117 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.90386393 |
118 | negative regulation of cell killing (GO:0031342) | 2.81098823 |
119 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.81098823 |
120 | diacylglycerol metabolic process (GO:0046339) | 2.80547057 |
121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78617110 |
122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77808838 |
123 | positive regulation of protein deacetylation (GO:0090312) | 2.76724698 |
124 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.76701176 |
125 | germinal center formation (GO:0002467) | 2.75317002 |
126 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72296348 |
127 | negative regulation of fatty acid transport (GO:2000192) | 2.71087713 |
128 | endothelial cell chemotaxis (GO:0035767) | 2.69318714 |
129 | T cell selection (GO:0045058) | 2.64912717 |
130 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60833203 |
131 | negative regulation of granulocyte differentiation (GO:0030853) | 2.60494871 |
132 | response to muramyl dipeptide (GO:0032495) | 2.59980161 |
133 | histone H3 deacetylation (GO:0070932) | 2.56846542 |
134 | histone H4 deacetylation (GO:0070933) | 2.54870351 |
135 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.53937189 |
136 | apoptotic process involved in morphogenesis (GO:0060561) | 2.51787692 |
137 | regulation of apoptotic cell clearance (GO:2000425) | 2.51543260 |
138 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.50946055 |
139 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.48268708 |
140 | regulation of monocyte differentiation (GO:0045655) | 2.47617593 |
141 | detection of bacterium (GO:0016045) | 2.47335515 |
142 | ethanol metabolic process (GO:0006067) | 2.46669901 |
143 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.45053778 |
144 | activation of JUN kinase activity (GO:0007257) | 2.42469154 |
145 | positive regulation of fatty acid oxidation (GO:0046321) | 2.41902572 |
146 | NIK/NF-kappaB signaling (GO:0038061) | 2.38803225 |
147 | negative thymic T cell selection (GO:0045060) | 2.36657367 |
148 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.35498534 |
149 | positive regulation of cholesterol efflux (GO:0010875) | 2.34967745 |
150 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.32974440 |
151 | regulation of fatty acid oxidation (GO:0046320) | 2.32051193 |
152 | regulation of extracellular matrix organization (GO:1903053) | 2.29558889 |
153 | skeletal muscle adaptation (GO:0043501) | 2.28474341 |
154 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.28014341 |
155 | regulation of triglyceride metabolic process (GO:0090207) | 2.27940635 |
156 | lysosome organization (GO:0007040) | 2.25843271 |
157 | lytic vacuole organization (GO:0080171) | 2.25843271 |
158 | tolerance induction (GO:0002507) | 2.25046106 |
159 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.24685670 |
160 | cell volume homeostasis (GO:0006884) | 2.24407277 |
161 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.23821683 |
162 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.22262263 |
163 | detection of other organism (GO:0098543) | 2.22185006 |
164 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.21531745 |
165 | acute-phase response (GO:0006953) | 2.20312572 |
166 | epoxygenase P450 pathway (GO:0019373) | 2.19144482 |
167 | retrograde transport, endosome to Golgi (GO:0042147) | 2.19079112 |
168 | histone H3-K4 trimethylation (GO:0080182) | 2.18672976 |
169 | quaternary ammonium group transport (GO:0015697) | 2.16590186 |
170 | negative regulation of innate immune response (GO:0045824) | 2.16258051 |
171 | cell-cell junction maintenance (GO:0045217) | 2.15733557 |
172 | negative regulation of interleukin-8 production (GO:0032717) | 2.14533913 |
173 | positive regulation of extracellular matrix organization (GO:1903055) | 2.13292636 |
174 | regulation of histone H3-K27 methylation (GO:0061085) | 2.13235409 |
175 | striated muscle atrophy (GO:0014891) | 2.13215689 |
176 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.13200800 |
177 | regulation of ruffle assembly (GO:1900027) | 2.13113802 |
178 | regulation of histone deacetylation (GO:0031063) | 2.12726514 |
179 | negative regulation of viral release from host cell (GO:1902187) | 2.11211328 |
180 | activation of MAPKKK activity (GO:0000185) | 2.09151349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.77834858 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.91766398 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.26887303 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.18544149 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.50788442 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.34783755 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28282096 |
8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15037755 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.44463772 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.21388535 |
11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05821085 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.99587890 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.79294607 |
14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.66689973 |
15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.35008317 |
16 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.30659224 |
17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.28613592 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.21254134 |
19 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.20256506 |
20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.18998013 |
21 | P68_20966046_ChIP-Seq_HELA_Human | 2.03032565 |
22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00699573 |
23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.91416010 |
24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88421138 |
25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.86011557 |
26 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.83590463 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74740697 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74293634 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70801447 |
30 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.70008111 |
31 | KDM2B_26808549_Chip-Seq_K562_Human | 1.69324309 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68289028 |
33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.67660481 |
34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66437757 |
35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62795287 |
36 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.62468702 |
37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.62070926 |
38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61590388 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60491915 |
40 | MAF_26560356_Chip-Seq_TH2_Human | 1.58558590 |
41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58534080 |
42 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.54725238 |
43 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.54300493 |
44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53850197 |
45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52597930 |
46 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.52141648 |
47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51927394 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51905199 |
49 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.50968712 |
50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45658223 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45384851 |
52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.45379270 |
53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45310611 |
54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40884880 |
55 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.37843464 |
56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33177560 |
57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32481673 |
58 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31272223 |
59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30955149 |
60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.30096698 |
61 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29644862 |
62 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28503251 |
63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25896947 |
64 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.23681554 |
65 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22322175 |
66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.20802579 |
67 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17007094 |
68 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16155913 |
69 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15736583 |
70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15523843 |
71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14532281 |
72 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14104190 |
73 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.13305167 |
74 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12905243 |
75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.11835868 |
76 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10972972 |
77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10830069 |
78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10551863 |
79 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.10017183 |
80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09182254 |
81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08391957 |
82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08141031 |
83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07118740 |
84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07039620 |
85 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06180828 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03983521 |
87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03283415 |
88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02643590 |
89 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02463668 |
90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02313503 |
91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00615678 |
92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00491141 |
93 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99941273 |
94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99926890 |
95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98454984 |
96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98267476 |
97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.96825596 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96321905 |
99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95769428 |
100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95747636 |
101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95057554 |
102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92155222 |
103 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91192964 |
104 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91085079 |
105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90095759 |
106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89724211 |
107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88965491 |
108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88234256 |
109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87543499 |
110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87223817 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86992212 |
112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86814511 |
113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86600561 |
114 | MAF_26560356_Chip-Seq_TH1_Human | 0.84525188 |
115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84261253 |
116 | MYC_22102868_ChIP-Seq_BL_Human | 0.83299335 |
117 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.82349948 |
118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80549774 |
119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79945350 |
120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79945350 |
121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79625732 |
122 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78945801 |
123 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.78283351 |
124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78054657 |
125 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77919936 |
126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76535020 |
127 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.73881256 |
128 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73685357 |
129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73414565 |
130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72668750 |
131 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72341699 |
132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72246643 |
133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72239505 |
134 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72158523 |
135 | * MYB_26560356_Chip-Seq_TH1_Human | 0.71087447 |
136 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70052285 |
137 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68528937 |
138 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.68378101 |
139 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.68243552 |
140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67893011 |
141 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65622132 |
142 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.65425254 |
143 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64695853 |
144 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.64657430 |
145 | UTX_26944678_Chip-Seq_JUKART_Human | 0.64266762 |
146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63940599 |
147 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.63083837 |
148 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62850261 |
149 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.62654817 |
150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60366398 |
151 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60357817 |
152 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.59538724 |
153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59075068 |
154 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58528031 |
155 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.58275152 |
156 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.58249462 |
157 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57821780 |
158 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57234618 |
159 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.56625418 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.76310099 |
2 | MP0005360_urolithiasis | 6.54347963 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.39157841 |
4 | MP0005365_abnormal_bile_salt | 5.36114660 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.10942455 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.82958610 |
7 | MP0003172_abnormal_lysosome_physiology | 3.64623879 |
8 | MP0003252_abnormal_bile_duct | 3.28008117 |
9 | MP0010329_abnormal_lipoprotein_level | 3.23593376 |
10 | MP0009840_abnormal_foam_cell | 3.07829057 |
11 | MP0005332_abnormal_amino_acid | 2.55363947 |
12 | MP0005083_abnormal_biliary_tract | 2.39290195 |
13 | MP0001666_abnormal_nutrient_absorption | 2.34207978 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.31201417 |
15 | MP0000609_abnormal_liver_physiology | 2.13954468 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.11340115 |
17 | MP0003195_calcinosis | 2.10836545 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.04274262 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.92108646 |
20 | MP0001849_ear_inflammation | 1.90973733 |
21 | MP0001873_stomach_inflammation | 1.84850589 |
22 | MP0004019_abnormal_vitamin_homeostasis | 1.82037610 |
23 | MP0005670_abnormal_white_adipose | 1.80905615 |
24 | MP0008260_abnormal_autophagy | 1.78821929 |
25 | MP0004130_abnormal_muscle_cell | 1.75504608 |
26 | MP0009278_abnormal_bone_marrow | 1.72392470 |
27 | MP0002933_joint_inflammation | 1.68948259 |
28 | MP0005076_abnormal_cell_differentiation | 1.68933333 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68262222 |
30 | MP0002249_abnormal_larynx_morphology | 1.68049759 |
31 | MP0003303_peritoneal_inflammation | 1.66575686 |
32 | MP0004947_skin_inflammation | 1.65491147 |
33 | MP0004381_abnormal_hair_follicle | 1.64622690 |
34 | MP0003763_abnormal_thymus_physiology | 1.64098533 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.60490497 |
36 | MP0001764_abnormal_homeostasis | 1.60239258 |
37 | MP0003868_abnormal_feces_composition | 1.56820259 |
38 | MP0010155_abnormal_intestine_physiology | 1.52191620 |
39 | MP0003186_abnormal_redox_activity | 1.51253496 |
40 | MP0009643_abnormal_urine_homeostasis | 1.48697973 |
41 | MP0005409_darkened_coat_color | 1.47217365 |
42 | MP0006036_abnormal_mitochondrial_physio | 1.44702219 |
43 | MP0000751_myopathy | 1.44363048 |
44 | MP0003879_abnormal_hair_cell | 1.43622082 |
45 | MP0009384_cardiac_valve_regurgitation | 1.42060842 |
46 | MP0000678_abnormal_parathyroid_gland | 1.41378681 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.40863291 |
48 | MP0003646_muscle_fatigue | 1.38610717 |
49 | MP0005666_abnormal_adipose_tissue | 1.34644605 |
50 | MP0002822_catalepsy | 1.33960579 |
51 | MP0005000_abnormal_immune_tolerance | 1.32797254 |
52 | MP0003279_aneurysm | 1.32576021 |
53 | MP0005671_abnormal_response_to | 1.31725979 |
54 | MP0009333_abnormal_splenocyte_physiolog | 1.31449655 |
55 | MP0002723_abnormal_immune_serum | 1.24232718 |
56 | MP0004858_abnormal_nervous_system | 1.23093106 |
57 | MP0000598_abnormal_liver_morphology | 1.22196224 |
58 | MP0009764_decreased_sensitivity_to | 1.20493117 |
59 | MP0003866_abnormal_defecation | 1.19909214 |
60 | MP0002452_abnormal_antigen_presenting | 1.19320496 |
61 | MP0001533_abnormal_skeleton_physiology | 1.18857198 |
62 | MP0003453_abnormal_keratinocyte_physiol | 1.17781845 |
63 | MP0003705_abnormal_hypodermis_morpholog | 1.15828207 |
64 | MP0003183_abnormal_peptide_metabolism | 1.15224072 |
65 | MP0001819_abnormal_immune_cell | 1.14977827 |
66 | MP0002998_abnormal_bone_remodeling | 1.14386559 |
67 | MP0002420_abnormal_adaptive_immunity | 1.13873187 |
68 | MP0001958_emphysema | 1.13424008 |
69 | MP0008469_abnormal_protein_level | 1.13036695 |
70 | MP0009763_increased_sensitivity_to | 1.12036677 |
71 | MP0000003_abnormal_adipose_tissue | 1.11918241 |
72 | MP0003878_abnormal_ear_physiology | 1.03976274 |
73 | MP0005377_hearing/vestibular/ear_phenot | 1.03976274 |
74 | MP0001348_abnormal_lacrimal_gland | 1.02597833 |
75 | MP0005451_abnormal_body_composition | 1.01120730 |
76 | MP0002254_reproductive_system_inflammat | 1.01049783 |
77 | MP0005636_abnormal_mineral_homeostasis | 0.99441203 |
78 | MP0000013_abnormal_adipose_tissue | 0.99389723 |
79 | MP0001853_heart_inflammation | 0.99331084 |
80 | MP0002971_abnormal_brown_adipose | 0.97502562 |
81 | MP0004510_myositis | 0.97054907 |
82 | MP0009697_abnormal_copulation | 0.96506014 |
83 | MP0002405_respiratory_system_inflammati | 0.95874937 |
84 | MP0003724_increased_susceptibility_to | 0.94746369 |
85 | MP0005084_abnormal_gallbladder_morpholo | 0.94068220 |
86 | MP0000685_abnormal_immune_system | 0.93831461 |
87 | MP0004043_abnormal_pH_regulation | 0.92228404 |
88 | MP0002876_abnormal_thyroid_physiology | 0.92144929 |
89 | MP0005330_cardiomyopathy | 0.91606656 |
90 | MP0000716_abnormal_immune_system | 0.91255956 |
91 | MP0002078_abnormal_glucose_homeostasis | 0.90742442 |
92 | MP0006035_abnormal_mitochondrial_morpho | 0.89846583 |
93 | MP0010234_abnormal_vibrissa_follicle | 0.89658163 |
94 | MP0009642_abnormal_blood_homeostasis | 0.89620033 |
95 | MP0003045_fibrosis | 0.88913817 |
96 | MP0005334_abnormal_fat_pad | 0.88238304 |
97 | MP0001663_abnormal_digestive_system | 0.86907066 |
98 | MP0010368_abnormal_lymphatic_system | 0.85299748 |
99 | MP0005464_abnormal_platelet_physiology | 0.84940222 |
100 | MP0001765_abnormal_ion_homeostasis | 0.83873740 |
101 | MP0002398_abnormal_bone_marrow | 0.83536708 |
102 | MP0005266_abnormal_metabolism | 0.83518614 |
103 | MP0000858_altered_metastatic_potential | 0.81838158 |
104 | MP0000681_abnormal_thyroid_gland | 0.81596914 |
105 | MP0005503_abnormal_tendon_morphology | 0.81402846 |
106 | MP0004185_abnormal_adipocyte_glucose | 0.80308413 |
107 | MP0003436_decreased_susceptibility_to | 0.80111353 |
108 | MP0005647_abnormal_sex_gland | 0.79796719 |
109 | MP0003300_gastrointestinal_ulcer | 0.78735730 |
110 | MP0005376_homeostasis/metabolism_phenot | 0.77679560 |
111 | MP0004036_abnormal_muscle_relaxation | 0.76774237 |
112 | MP0001835_abnormal_antigen_presentation | 0.76742274 |
113 | MP0009115_abnormal_fat_cell | 0.72888192 |
114 | MP0009765_abnormal_xenobiotic_induced | 0.72446999 |
115 | MP0004084_abnormal_cardiac_muscle | 0.70538277 |
116 | MP0002396_abnormal_hematopoietic_system | 0.69976734 |
117 | MP0002136_abnormal_kidney_physiology | 0.68427804 |
118 | MP0009785_altered_susceptibility_to | 0.68016104 |
119 | MP0005535_abnormal_body_temperature | 0.66014619 |
120 | MP0000604_amyloidosis | 0.65518015 |
121 | MP0001756_abnormal_urination | 0.65216174 |
122 | MP0003011_delayed_dark_adaptation | 0.65085587 |
123 | MP0005375_adipose_tissue_phenotype | 0.64305649 |
124 | MP0002166_altered_tumor_susceptibility | 0.64095222 |
125 | MP0010630_abnormal_cardiac_muscle | 0.63843981 |
126 | MP0005058_abnormal_lysosome_morphology | 0.63258993 |
127 | MP0001544_abnormal_cardiovascular_syste | 0.62815804 |
128 | MP0005385_cardiovascular_system_phenoty | 0.62815804 |
129 | MP0005025_abnormal_response_to | 0.62752200 |
130 | MP0001845_abnormal_inflammatory_respons | 0.61102422 |
131 | MP0001800_abnormal_humoral_immune | 0.60868377 |
132 | MP0004215_abnormal_myocardial_fiber | 0.59945782 |
133 | MP0002132_abnormal_respiratory_system | 0.59829796 |
134 | MP0002928_abnormal_bile_duct | 0.59616304 |
135 | MP0001790_abnormal_immune_system | 0.57446150 |
136 | MP0005387_immune_system_phenotype | 0.57446150 |
137 | MP0008961_abnormal_basal_metabolism | 0.56933777 |
138 | MP0005448_abnormal_energy_balance | 0.55988869 |
139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55074251 |
140 | MP0002970_abnormal_white_adipose | 0.54951600 |
141 | MP0001661_extended_life_span | 0.52975590 |
142 | MP0004087_abnormal_muscle_fiber | 0.51813026 |
143 | MP0000249_abnormal_blood_vessel | 0.51573083 |
144 | MP0002419_abnormal_innate_immunity | 0.51362136 |
145 | MP0002269_muscular_atrophy | 0.50654280 |
146 | MP0005397_hematopoietic_system_phenotyp | 0.50636055 |
147 | MP0001545_abnormal_hematopoietic_system | 0.50636055 |
148 | MP0000343_altered_response_to | 0.49710463 |
149 | MP0006138_congestive_heart_failure | 0.47864858 |
150 | MP0004147_increased_porphyrin_level | 0.47716351 |
151 | MP0000230_abnormal_systemic_arterial | 0.47367611 |
152 | MP0000689_abnormal_spleen_morphology | 0.47045844 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.09694922 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.78658945 |
3 | Deep venous thrombosis (HP:0002625) | 5.54466564 |
4 | Xanthomatosis (HP:0000991) | 5.29794180 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.01372997 |
6 | Hypobetalipoproteinemia (HP:0003563) | 4.95507862 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 4.84192714 |
8 | Hyperammonemia (HP:0001987) | 4.79404978 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.77733418 |
10 | Obstructive sleep apnea (HP:0002870) | 4.67349879 |
11 | Ketosis (HP:0001946) | 4.56555782 |
12 | Hypoglycemic coma (HP:0001325) | 4.34439593 |
13 | Hyperglycinuria (HP:0003108) | 4.31137454 |
14 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.28295524 |
15 | Complement deficiency (HP:0004431) | 4.11451421 |
16 | J-shaped sella turcica (HP:0002680) | 4.10967607 |
17 | Abnormality of glycine metabolism (HP:0010895) | 4.08388222 |
18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.08388222 |
19 | Hyperglycinemia (HP:0002154) | 4.07604451 |
20 | Broad face (HP:0000283) | 4.07083861 |
21 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.96463865 |
22 | Hypolipoproteinemia (HP:0010981) | 3.90921522 |
23 | Joint hemorrhage (HP:0005261) | 3.87607352 |
24 | Epidermoid cyst (HP:0200040) | 3.78185691 |
25 | Dysostosis multiplex (HP:0000943) | 3.76504828 |
26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.75379052 |
27 | Ketoacidosis (HP:0001993) | 3.74857077 |
28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.71744333 |
29 | Mucopolysacchariduria (HP:0008155) | 3.68266455 |
30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.68266455 |
31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.67014221 |
32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.67014221 |
33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.67014221 |
34 | Cervical subluxation (HP:0003308) | 3.60175715 |
35 | Hypoalphalipoproteinemia (HP:0003233) | 3.56871100 |
36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.53818468 |
37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.48963755 |
38 | * Dicarboxylic aciduria (HP:0003215) | 3.48594908 |
39 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.48594908 |
40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.40514453 |
41 | Thin bony cortex (HP:0002753) | 3.37278834 |
42 | Abnormality of methionine metabolism (HP:0010901) | 3.33689295 |
43 | Conjugated hyperbilirubinemia (HP:0002908) | 3.24342050 |
44 | Colitis (HP:0002583) | 3.21836320 |
45 | Hyperbilirubinemia (HP:0002904) | 3.20855997 |
46 | Generalized aminoaciduria (HP:0002909) | 3.14693811 |
47 | Fat malabsorption (HP:0002630) | 3.14170223 |
48 | Exercise-induced myalgia (HP:0003738) | 3.13966479 |
49 | Abnormality of the intrinsic pathway (HP:0010989) | 3.12792206 |
50 | Abnormality of serum amino acid levels (HP:0003112) | 3.03090887 |
51 | Joint stiffness (HP:0001387) | 2.99505295 |
52 | Cerebral aneurysm (HP:0004944) | 2.99213101 |
53 | Hypercholesterolemia (HP:0003124) | 2.97387117 |
54 | Metabolic acidosis (HP:0001942) | 2.96595672 |
55 | Abnormality of complement system (HP:0005339) | 2.95669991 |
56 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.85670365 |
57 | Asymmetric septal hypertrophy (HP:0001670) | 2.82621963 |
58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81364655 |
59 | Myocardial infarction (HP:0001658) | 2.80038357 |
60 | Abnormality of purine metabolism (HP:0004352) | 2.79211800 |
61 | Lethargy (HP:0001254) | 2.77533670 |
62 | Myopathic facies (HP:0002058) | 2.76212518 |
63 | Lymphangioma (HP:0100764) | 2.72830922 |
64 | Cerebral edema (HP:0002181) | 2.68787214 |
65 | Increased connective tissue (HP:0009025) | 2.67402411 |
66 | Deformed sella turcica (HP:0002681) | 2.61685688 |
67 | Myoglobinuria (HP:0002913) | 2.58206201 |
68 | Eczematoid dermatitis (HP:0000976) | 2.57404068 |
69 | Biconcave vertebral bodies (HP:0004586) | 2.57022409 |
70 | Glomerulonephritis (HP:0000099) | 2.55151634 |
71 | Hepatocellular carcinoma (HP:0001402) | 2.54629135 |
72 | Increased IgE level (HP:0003212) | 2.53571560 |
73 | Emphysema (HP:0002097) | 2.52864628 |
74 | Gout (HP:0001997) | 2.50313437 |
75 | * Stridor (HP:0010307) | 2.47356053 |
76 | * Delayed CNS myelination (HP:0002188) | 2.43546949 |
77 | Gastrointestinal inflammation (HP:0004386) | 2.43240678 |
78 | Easy fatigability (HP:0003388) | 2.41042265 |
79 | Cerebral palsy (HP:0100021) | 2.40047619 |
80 | * Vomiting (HP:0002013) | 2.38921193 |
81 | Distal lower limb amyotrophy (HP:0008944) | 2.38452016 |
82 | Flat acetabular roof (HP:0003180) | 2.37250199 |
83 | Skin nodule (HP:0200036) | 2.37100656 |
84 | Distal lower limb muscle weakness (HP:0009053) | 2.36635449 |
85 | Hepatic necrosis (HP:0002605) | 2.33605685 |
86 | Hypochromic microcytic anemia (HP:0004840) | 2.32923519 |
87 | Acanthocytosis (HP:0001927) | 2.30554067 |
88 | Steatorrhea (HP:0002570) | 2.29317273 |
89 | Late onset (HP:0003584) | 2.29182810 |
90 | Nausea (HP:0002018) | 2.29051300 |
91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28030193 |
92 | Increased cerebral lipofuscin (HP:0011813) | 2.27089897 |
93 | Thoracic kyphosis (HP:0002942) | 2.26430590 |
94 | Inflammation of the large intestine (HP:0002037) | 2.26159323 |
95 | Pancreatitis (HP:0001733) | 2.26032302 |
96 | Vascular calcification (HP:0004934) | 2.25595808 |
97 | Hypoglycemic seizures (HP:0002173) | 2.25168524 |
98 | Renal cortical cysts (HP:0000803) | 2.23998980 |
99 | Abnormality of the fingertips (HP:0001211) | 2.22365584 |
100 | Neonatal onset (HP:0003623) | 2.20090852 |
101 | Abnormality of the thoracic spine (HP:0100711) | 2.19898913 |
102 | Hydroxyprolinuria (HP:0003080) | 2.19319892 |
103 | Abnormality of proline metabolism (HP:0010907) | 2.19319892 |
104 | Rhabdomyolysis (HP:0003201) | 2.18986471 |
105 | Nuclear cataract (HP:0100018) | 2.18359216 |
106 | Systemic lupus erythematosus (HP:0002725) | 2.17659119 |
107 | Ulnar deviation of the wrist (HP:0003049) | 2.16506759 |
108 | Gingival bleeding (HP:0000225) | 2.15372172 |
109 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15244240 |
110 | Proximal tubulopathy (HP:0000114) | 2.14158357 |
111 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12655770 |
112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12176714 |
113 | Spontaneous abortion (HP:0005268) | 2.11859841 |
114 | Myositis (HP:0100614) | 2.10679752 |
115 | Flared iliac wings (HP:0002869) | 2.10278860 |
116 | Cholelithiasis (HP:0001081) | 2.08493059 |
117 | Round ear (HP:0100830) | 2.08078719 |
118 | Purpura (HP:0000979) | 2.06592870 |
119 | Esophageal varix (HP:0002040) | 2.05726039 |
120 | Abnormal gallbladder morphology (HP:0012437) | 2.05126439 |
121 | Polygenic inheritance (HP:0010982) | 2.04077024 |
122 | Brushfield spots (HP:0001088) | 2.03570367 |
123 | Thrombophlebitis (HP:0004418) | 2.02907261 |
124 | Increased muscle lipid content (HP:0009058) | 2.02768406 |
125 | Mitral stenosis (HP:0001718) | 2.02559582 |
126 | Gastrointestinal stroma tumor (HP:0100723) | 2.02513173 |
127 | Nephritis (HP:0000123) | 2.02277356 |
128 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00643624 |
129 | Hyperuricemia (HP:0002149) | 1.99289944 |
130 | Increased purine levels (HP:0004368) | 1.99289944 |
131 | Seborrheic dermatitis (HP:0001051) | 1.99226890 |
132 | Elevated hepatic transaminases (HP:0002910) | 1.99088961 |
133 | Bulbar palsy (HP:0001283) | 1.98693993 |
134 | Prolonged bleeding time (HP:0003010) | 1.98559078 |
135 | Spastic diplegia (HP:0001264) | 1.97696997 |
136 | Cardiovascular calcification (HP:0011915) | 1.97451691 |
137 | Atelectasis (HP:0100750) | 1.95954974 |
138 | Increased serum ferritin (HP:0003281) | 1.95744853 |
139 | Pustule (HP:0200039) | 1.94762619 |
140 | Hypertriglyceridemia (HP:0002155) | 1.94001490 |
141 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93827160 |
142 | Irritability (HP:0000737) | 1.93738716 |
143 | Hyperacusis (HP:0010780) | 1.93361594 |
144 | Polycythemia (HP:0001901) | 1.93078957 |
145 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92321635 |
146 | Spinal canal stenosis (HP:0003416) | 1.90723250 |
147 | Aneurysm (HP:0002617) | 1.89902893 |
148 | Poikilocytosis (HP:0004447) | 1.89733157 |
149 | Abnormality of urine glucose concentration (HP:0011016) | 1.89105270 |
150 | Glycosuria (HP:0003076) | 1.89105270 |
151 | Palpitations (HP:0001962) | 1.88008644 |
152 | Gingivitis (HP:0000230) | 1.87994031 |
153 | Abnormality of iron homeostasis (HP:0011031) | 1.87725581 |
154 | Restrictive lung disease (HP:0002091) | 1.87584660 |
155 | Opisthotonus (HP:0002179) | 1.86766696 |
156 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86305169 |
157 | Diaphragmatic weakness (HP:0009113) | 1.85721576 |
158 | Right ventricular cardiomyopathy (HP:0011663) | 1.84158917 |
159 | Ragged-red muscle fibers (HP:0003200) | 1.84136131 |
160 | Mitral regurgitation (HP:0001653) | 1.84098154 |
161 | Hemorrhage of the eye (HP:0011885) | 1.83989324 |
162 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82064144 |
163 | Type 1 muscle fiber predominance (HP:0003803) | 1.81301853 |
164 | Gastrointestinal infarctions (HP:0005244) | 1.81016953 |
165 | Hyperglycemia (HP:0003074) | 1.80536346 |
166 | Malnutrition (HP:0004395) | 1.80517820 |
167 | Amyloidosis (HP:0011034) | 1.80200442 |
168 | Hypophosphatemia (HP:0002148) | 1.79719654 |
169 | Recurrent fungal infections (HP:0002841) | 1.79467081 |
170 | Hypoplasia of the odontoid process (HP:0003311) | 1.73934473 |
171 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.73364948 |
172 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73282438 |
173 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73282438 |
174 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73282438 |
175 | Distal upper limb amyotrophy (HP:0007149) | 1.71213932 |
176 | Upper limb amyotrophy (HP:0009129) | 1.71213932 |
177 | Bronchomalacia (HP:0002780) | 1.70410258 |
178 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.70397760 |
179 | Loss of speech (HP:0002371) | 1.69967122 |
180 | Abnormality of the sella turcica (HP:0002679) | 1.69910529 |
181 | Visceral angiomatosis (HP:0100761) | 1.65932790 |
182 | Abnormality of the Achilles tendon (HP:0005109) | 1.65145068 |
183 | Protrusio acetabuli (HP:0003179) | 1.64813692 |
184 | Obstructive lung disease (HP:0006536) | 1.64112322 |
185 | Chronic obstructive pulmonary disease (HP:0006510) | 1.64112322 |
186 | Menorrhagia (HP:0000132) | 1.63558719 |
187 | Rectal prolapse (HP:0002035) | 1.63081629 |
188 | Cellulitis (HP:0100658) | 1.63054924 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.67102268 |
2 | FLT3 | 3.49450562 |
3 | ERN1 | 3.31342284 |
4 | PKN2 | 2.94550161 |
5 | FGFR4 | 2.73805748 |
6 | SIK1 | 2.66821870 |
7 | TNK2 | 2.45826776 |
8 | TAOK3 | 2.34310869 |
9 | TRIB3 | 2.32864143 |
10 | EEF2K | 2.21578158 |
11 | MAP4K1 | 2.17006747 |
12 | TYK2 | 2.06262351 |
13 | ICK | 1.89387794 |
14 | SMG1 | 1.88993395 |
15 | KIT | 1.76010516 |
16 | RIPK4 | 1.73896995 |
17 | TTN | 1.73753357 |
18 | PRPF4B | 1.71325725 |
19 | MAPK11 | 1.70108645 |
20 | INSRR | 1.64897903 |
21 | MAPKAPK3 | 1.61922579 |
22 | MARK2 | 1.61563247 |
23 | TBK1 | 1.59686141 |
24 | SIK2 | 1.59170054 |
25 | MAP3K14 | 1.57111191 |
26 | CDC42BPA | 1.55741131 |
27 | MAP2K6 | 1.53922958 |
28 | RIPK1 | 1.49028729 |
29 | MAP2K3 | 1.47588203 |
30 | PRKD2 | 1.47403371 |
31 | CSF1R | 1.47257526 |
32 | TIE1 | 1.45745453 |
33 | STK16 | 1.44373243 |
34 | PRKAA2 | 1.43585303 |
35 | BTK | 1.41405427 |
36 | GRK6 | 1.40444287 |
37 | PDK3 | 1.39928945 |
38 | PDK4 | 1.39928945 |
39 | EPHA2 | 1.36879740 |
40 | TRPM7 | 1.32110861 |
41 | TGFBR2 | 1.31519253 |
42 | MYLK | 1.26588009 |
43 | MAP3K10 | 1.25723815 |
44 | BLK | 1.24194559 |
45 | TEC | 1.22730491 |
46 | NEK9 | 1.17425160 |
47 | RPS6KA2 | 1.15210146 |
48 | IRAK3 | 1.12642065 |
49 | PTK6 | 1.12542622 |
50 | KDR | 1.11289561 |
51 | JAK1 | 1.10310300 |
52 | PIK3CG | 1.09987281 |
53 | MST1R | 1.08332769 |
54 | JAK3 | 1.07729835 |
55 | MAP3K7 | 1.05579521 |
56 | JAK2 | 1.04194249 |
57 | IKBKE | 1.02053322 |
58 | LMTK2 | 1.02023344 |
59 | ITK | 1.01177623 |
60 | CAMKK1 | 1.00965038 |
61 | NME2 | 1.00024020 |
62 | HIPK2 | 0.98025853 |
63 | NME1 | 0.97852103 |
64 | MAPK12 | 0.94360949 |
65 | ZAP70 | 0.92410426 |
66 | PDK2 | 0.88206062 |
67 | MTOR | 0.85536282 |
68 | PDPK1 | 0.84837796 |
69 | MAPK4 | 0.84181381 |
70 | NLK | 0.82159152 |
71 | CDK12 | 0.81446677 |
72 | CHUK | 0.80395211 |
73 | PHKG1 | 0.78571487 |
74 | PHKG2 | 0.78571487 |
75 | OBSCN | 0.78570694 |
76 | MAP3K3 | 0.78235664 |
77 | CAMK1D | 0.78101443 |
78 | TGFBR1 | 0.76858777 |
79 | PRKAA1 | 0.75026688 |
80 | TAOK1 | 0.74383060 |
81 | MAP3K1 | 0.74308775 |
82 | BMX | 0.73280071 |
83 | FRK | 0.72652854 |
84 | DDR2 | 0.72057154 |
85 | PIK3CA | 0.71323664 |
86 | FES | 0.69382742 |
87 | PINK1 | 0.68742801 |
88 | SYK | 0.68216272 |
89 | TYRO3 | 0.67493139 |
90 | MAP2K2 | 0.66867787 |
91 | MAPK7 | 0.65554063 |
92 | EPHB1 | 0.65075086 |
93 | PDK1 | 0.64992076 |
94 | SIK3 | 0.64567935 |
95 | PRKD3 | 0.62032393 |
96 | FGFR2 | 0.59664269 |
97 | FGFR3 | 0.58980487 |
98 | ACVR1B | 0.58692341 |
99 | CSK | 0.58417403 |
100 | PDGFRA | 0.57817904 |
101 | MAPK15 | 0.57632209 |
102 | CDK4 | 0.55625421 |
103 | ABL2 | 0.54161429 |
104 | LRRK2 | 0.53329499 |
105 | DYRK1B | 0.53103631 |
106 | ERBB2 | 0.52457797 |
107 | RET | 0.52171931 |
108 | TXK | 0.51788945 |
109 | RPS6KA6 | 0.51123660 |
110 | CDK6 | 0.50081513 |
111 | PRKCH | 0.49100068 |
112 | PRKACG | 0.48643571 |
113 | DAPK2 | 0.48382979 |
114 | STK10 | 0.47807784 |
115 | MAP3K11 | 0.47488402 |
116 | EPHA3 | 0.47464927 |
117 | MAP3K13 | 0.46768987 |
118 | SGK3 | 0.46577518 |
119 | IKBKB | 0.46224052 |
120 | PRKG2 | 0.44985011 |
121 | HCK | 0.44343402 |
122 | SGK2 | 0.44212278 |
123 | MAPK3 | 0.43885766 |
124 | RPS6KB2 | 0.43602076 |
125 | PIM1 | 0.43115870 |
126 | RPS6KC1 | 0.43030309 |
127 | RPS6KL1 | 0.43030309 |
128 | RPS6KA4 | 0.42963535 |
129 | STK38 | 0.41554049 |
130 | MAP2K4 | 0.39078464 |
131 | IGF1R | 0.38645256 |
132 | LCK | 0.38578980 |
133 | MAPK8 | 0.38426189 |
134 | PRKCQ | 0.38103693 |
135 | MATK | 0.37673715 |
136 | PRKD1 | 0.37610544 |
137 | MARK3 | 0.36888260 |
138 | PDGFRB | 0.36800830 |
139 | CAMK4 | 0.35164986 |
140 | STK4 | 0.35009373 |
141 | IRAK4 | 0.33727406 |
142 | MAP3K6 | 0.32414915 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.25972261 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.88415503 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33903870 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.13541487 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.07559535 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.95670357 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.80016993 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.76204967 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75391769 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69783907 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.56196554 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51794443 |
13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.48676138 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24198839 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23126834 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.22319412 |
17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22105718 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19979864 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.18505076 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.10571923 |
21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.94738984 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86695220 |
23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.84907501 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77690208 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70897064 |
26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.65104067 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61370914 |
28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57964000 |
29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57308721 |
30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55319432 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54293902 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53701833 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53148462 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49993026 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45555400 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45196871 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45044800 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42202441 |
39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40841876 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37071131 |
41 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36909071 |
42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.36332151 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35202656 |
44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35015273 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32813625 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30985619 |
47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27665134 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26491366 |
49 | ABC transporters_Homo sapiens_hsa02010 | 1.26122471 |
50 | Bile secretion_Homo sapiens_hsa04976 | 1.22812555 |
51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20818151 |
52 | Lysosome_Homo sapiens_hsa04142 | 1.20477728 |
53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18636775 |
54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15703056 |
55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09403323 |
56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08378935 |
57 | Lysine degradation_Homo sapiens_hsa00310 | 1.08229842 |
58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07527639 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06232802 |
60 | Allograft rejection_Homo sapiens_hsa05330 | 1.03583794 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03576581 |
62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02769380 |
63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02055420 |
64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01908129 |
65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01075773 |
66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00944915 |
67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00219173 |
68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98840644 |
69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98535073 |
70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93234345 |
71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93151781 |
72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92853805 |
73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90055275 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88845728 |
75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87426352 |
76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86980272 |
77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86334930 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85946645 |
79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85821588 |
80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85772816 |
81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83356007 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82916287 |
83 | Asthma_Homo sapiens_hsa05310 | 0.82617685 |
84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82600780 |
85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81185283 |
86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80851327 |
87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78108862 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76022230 |
89 | Tuberculosis_Homo sapiens_hsa05152 | 0.75023215 |
90 | Influenza A_Homo sapiens_hsa05164 | 0.73180207 |
91 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71200245 |
92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70864090 |
93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70098079 |
94 | Platelet activation_Homo sapiens_hsa04611 | 0.69315748 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66807130 |
96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66638375 |
97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63311786 |
98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59637989 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59167278 |
100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57873476 |
101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57574934 |
102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57234837 |
103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56943133 |
104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55993664 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55731845 |
106 | Insulin resistance_Homo sapiens_hsa04931 | 0.54822990 |
107 | Bladder cancer_Homo sapiens_hsa05219 | 0.54480800 |
108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53097122 |
109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49334256 |
110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48380271 |
111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48322045 |
112 | Hepatitis B_Homo sapiens_hsa05161 | 0.47978640 |
113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47734070 |
114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46853995 |
115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46214937 |
116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46066420 |
117 | Amoebiasis_Homo sapiens_hsa05146 | 0.44782615 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42399420 |
119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41848919 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41535318 |
121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39152717 |
122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28530185 |
123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22554788 |
124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21722616 |
125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14000742 |
126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10890290 |
127 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.07060075 |
128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06190378 |
129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.03262892 |
130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02915833 |
131 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.00943153 |
132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.1632948 |
133 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1620619 |
134 | Measles_Homo sapiens_hsa05162 | -0.1595602 |
135 | Pertussis_Homo sapiens_hsa05133 | -0.1589373 |
136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1547715 |
137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1528421 |
138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1368587 |
139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1346137 |
140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1305940 |
141 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1207521 |
142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0703454 |
143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0554565 |
144 | Legionellosis_Homo sapiens_hsa05134 | -0.0424501 |
145 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0408453 |
146 | Hepatitis C_Homo sapiens_hsa05160 | -0.0326585 |
147 | Prion diseases_Homo sapiens_hsa05020 | -0.0207336 |
148 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0141905 |
149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0090005 |